Avior Wealth Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-45
| Closed | -$939 | – | 1072 |
|
2024
Q4 | $939 | Hold |
45
| – | – | ﹤0.01% | 2204 |
|
2024
Q3 | $894 | Hold |
45
| – | – | ﹤0.01% | 2085 |
|
2024
Q2 | $697 | Sell |
45
-19
| -30% | -$294 | ﹤0.01% | 2074 |
|
2024
Q1 | $1.02K | Buy |
64
+19
| +42% | +$303 | ﹤0.01% | 2395 |
|
2023
Q4 | $756 | Hold |
45
| – | – | ﹤0.01% | 1395 |
|
2023
Q3 | $526 | Hold |
45
| – | – | ﹤0.01% | 1487 |
|
2023
Q2 | $604 | Hold |
45
| – | – | ﹤0.01% | 1447 |
|
2023
Q1 | $746 | Hold |
45
| – | – | ﹤0.01% | 1484 |
|
2022
Q4 | $837 | Hold |
45
| – | – | ﹤0.01% | 1136 |
|
2022
Q3 | $0 | Hold |
45
| – | – | ﹤0.01% | 1169 |
|
2022
Q2 | $0 | Hold |
45
| – | – | ﹤0.01% | 1086 |
|
2022
Q1 | $0 | Hold |
45
| – | – | ﹤0.01% | 1119 |
|
2021
Q4 | $0 | Hold |
45
| – | – | ﹤0.01% | 1110 |
|
2021
Q3 | $0 | Buy |
+45
| New | – | ﹤0.01% | 1072 |
|